Sansure Biotech Inc (688289) — Net Asset Quality Index
Sansure Biotech Inc (688289) has a Net Asset Quality Index of 75.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥9.61 Billion minus total liabilities of CN¥2.38 Billion yields net assets of CN¥7.23 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Sansure Biotech Inc's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sansure Biotech Inc Net Asset Quality Index Over Time (2017–2025)
This chart shows how Sansure Biotech Inc's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the index stands at 75.3%, representing net assets of CN¥7.23 Billion against total assets of CN¥9.61 Billion CNY. See working capital position of Sansure Biotech Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Sansure Biotech Inc (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Sansure Biotech Inc from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 688289 stock market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 175.8% | CN¥16.75 Billion | CN¥9.53 Billion | CN¥-7.22 Billion | ▲ +90.4 pp |
| 2024 | 85.4% | CN¥7.35 Billion | CN¥8.60 Billion | CN¥1.26 Billion | ▼ -2.4 pp |
| 2023 | 87.8% | CN¥7.42 Billion | CN¥8.45 Billion | CN¥1.03 Billion | ▲ +5.9 pp |
| 2022 | 81.9% | CN¥7.51 Billion | CN¥9.17 Billion | CN¥1.66 Billion | ▼ -8.1 pp |
| 2021 | 90.0% | CN¥6.38 Billion | CN¥7.09 Billion | CN¥709.03 Million | ▲ +3.0 pp |
| 2020 | 87.0% | CN¥4.75 Billion | CN¥5.45 Billion | CN¥708.95 Million | ▲ +0.2 pp |
| 2019 | 86.8% | CN¥557.48 Million | CN¥642.47 Million | CN¥84.99 Million | ▲ +15.0 pp |
| 2018 | 71.8% | CN¥396.29 Million | CN¥552.04 Million | CN¥155.76 Million | ▲ +4.8 pp |
| 2017 | 67.0% | CN¥378.99 Million | CN¥565.61 Million | CN¥186.62 Million | — |